Elanco Animal Health Research and Development Expenses 2016-2024 | ELAN

Elanco Animal Health annual/quarterly research and development expenses history and growth rate from 2016 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Elanco Animal Health research and development expenses for the quarter ending March 31, 2024 were $0.087B, a 7.41% increase year-over-year.
  • Elanco Animal Health research and development expenses for the twelve months ending March 31, 2024 were $333M, a 3.74% increase year-over-year.
  • Elanco Animal Health annual research and development expenses for 2023 were $0.327B, a 1.87% increase from 2022.
  • Elanco Animal Health annual research and development expenses for 2022 were $0.321B, a 13.01% decline from 2021.
  • Elanco Animal Health annual research and development expenses for 2021 were $0.369B, a 12.16% increase from 2020.
Elanco Animal Health Annual Research and Development Expenses
(Millions of US $)
2023 $327
2022 $321
2021 $369
2020 $329
2019 $270
2018 $247
2017 $252
2016 $266
2015 $291
Elanco Animal Health Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $87
2023-12-31 $79
2023-09-30 $86
2023-06-30 $81
2023-03-31 $81
2022-12-31 $80
2022-09-30 $78
2022-06-30 $82
2022-03-31 $81
2021-12-31 $92
2021-09-30 $94
2021-06-30 $94
2021-03-31 $89
2020-12-31 $115
2020-09-30 $88
2020-06-30 $59
2020-03-31 $67
2019-12-31 $67
2019-09-30 $70
2019-06-30 $69
2019-03-31 $64
2018-12-31 $61
2018-09-30 $59
2018-06-30 $61
2018-03-31 $65
2017-12-31
2017-09-30 $62
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.401B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.429B 10.54
Quest Diagnostics (DGX) United States $15.377B 15.89
DaVita (DVA) United States $12.061B 14.98
Encompass Health (EHC) United States $8.712B 22.30
Chemed (CHE) United States $8.709B 26.99
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.083B 85.00
Amedisys (AMED) United States $3.121B 22.11
LifeStance Health (LFST) United States $2.622B 0.00
Astrana Health (ASTH) United States $2.179B 29.46
Addus HomeCare (ADUS) United States $1.789B 25.59
U.S Physical Therapy (USPH) United States $1.603B 42.90
Pennant (PNTG) United States $0.680B 35.94
Aveanna Healthcare Holdings (AVAH) United States $0.481B 0.00
Atai Life Sciences (ATAI) Germany $0.316B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00